Screener
Stoke Therapeutics, Inc. STOK PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211874
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Marketable securities - long-term | 67,481 | 106,260 |
| Restricted cash - long-term | 3,227 | 227 |
| Operating lease right-of-use assets | 2,493 | 3,101 |
| Property and equipment, net | 3,395 | 3,146 |
| Total assets | $443,277 | $418,434 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $6,839 | $4,939 |
Item 1. Financial Statements.
FAQ
- What is Stoke Therapeutics, Inc.'s PP&E (net)?
- Stoke Therapeutics, Inc. (STOK) reported PP&E (net) of $3.4M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s PP&E (net) changed year-over-year?
- Stoke Therapeutics, Inc.'s PP&E (net) decreased by 6.0% year-over-year, from $3.61M to $3.4M.
- What is the long-term trend for Stoke Therapeutics, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s PP&E (net) has grown at a 3.3% compound annual growth rate (CAGR), from $2.68M to $3.15M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Stoke Therapeutics, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude